Crossmark

Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

Crossref DOI link: https://doi.org/10.1038/s41379-021-00738-5

Published Print: 2021-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Katayama, Ayaka https://orcid.org/0000-0002-8667-158X
Miligy, Islam M.

Shiino, Sho

Toss, Michael S. https://orcid.org/0000-0002-9077-3984
Eldib, Karim

Kurozumi, Sasagu

Quinn, Cecily M.

Badr, Nahla

Murray, Ciara

Provenzano, Elena https://orcid.org/0000-0003-3345-3965
Callagy, Grace

Martyn, Cian

Millican-Slater, Rebecca

Purdie, Colin https://orcid.org/0000-0002-1258-4010
Purnell, Dave

Pinder, Sarah E. https://orcid.org/0000-0003-4167-8910
Oyama, Tetsunari

Shaaban, Abeer M.

Ellis, Ian https://orcid.org/0000-0001-5292-8474
Lee, Andrew H.S.

Rakha, Emad A.
License Information

Text and Data Mining valid from 2021-07-01

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2023-01-05
More Information

This article is maintained by: Elsevier

Article Title: Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-021-00738-5

Content Type: article

Copyright: © 2021 The Authors.

Document is current

Any future updates will be listed below